Bronchiectasis: so much yet to learn and to do

Paediatric Respiratory Reviews

Volumn 12, Issue 2, 2011, Pages 89-90

  Chang, A B ^a,b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; FATTY ACID DERIVATIVE; LIPOXIN; RESOLVIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; BRONCHIECTASIS; CYSTIC FIBROSIS; DELAYED DIAGNOSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EDITORIAL; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; GEOGRAPHIC DISTRIBUTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOST PATHOGEN INTERACTION; INFLAMMATION; INNATE IMMUNITY; LUNG FUNCTION TEST; MORTALITY; NEUTROPHIL CHEMOTAXIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL;

BRONCHIECTASIS; HUMANS;

EID: 79953191056     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2011.01.001     Document Type: Editorial

References (25)

1. Chang A.B., Bell S.C., Byrnes C.A., et al. Bronchiectasis and chronic suppurative lung disease (CSLD) in children and adults in Australian and New Zealand: Thoracic Society of Australia and New Zealand and Australian Lung Foundation Position Statement. Med J Aust 2010, 193:356-365.
2. Field C.E., Bronchiectasis: Third report on a follow-up study of medical and surgical cases from childhood. Arch Dis Child 1969, 44:551-561.
3. Field C.E. Bronchiectasis in childhood: II. Aetiology and Pathogenesis, Including a Survey of 272 Cases of Doubtful Irreversible Bronchiectasis. Pediatrics 1949, 4:231-248.
4. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008, 14:595-599.
5. Twiss J., Metcalfe R., Edwards E.A., Byrnes C. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005, 90:737-740.
6. King P.T., Holdsworth S.R., Freezer N.J., Villanueva E., Gallagher M., Holmes P.W. Outcome in adult bronchiectasis. COPD 2005, 2:27-34.
7. Kapur N., Karadag B. Differences and similarities in non-CF BE between developing and affluent countries. Paediatr Respir Rev 2011, 12:91-96.
8. Seitz A.E., Olivier K.N., Steiner C.A., De Oca R.M., Holland S.M., Prevots D.R. Trends and Burden of Bronchiectasis-Associated Hospitalizations: USA, 1993-2006. Chest 2010, 138:944-949.
9. accessed 24th Dec 2010 2010. http://www.cff.org/AboutCF/Faqs.
10. Weycker D., Edelsberg J., Oster G., Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med 2005, 12:205-209.
11. King P.T., Holdsworth S.R., Farmer M., Freezer N., Villanueva E., Holmes P.W. Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood. COPD 2009, 6:130-136.
12. Chang A.B., Byrnes C.A., Everard M.L. Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis. Paediatr Respir Rev 2011, 12:97-103.
13. Long F.R., Williams R.S., Castile R.G. Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 2004, 144:154-161.
14. Kapur N., Masel J.P., Watson D., Masters I.B., Chang A.B. Bronchoarterial ratio on High Resolution CT scan of the chest in children without pulmonary pathology- Need to redefine bronchial dilatation. Chest 2010, Sep 23 [Epub ahead of print].
15. King P.T. Pathogenesis of bronchiectasis. Paediatr Respir Rev 2011, 12:104-110.
16. Cowburn A.S., Condliffe A.M., Farahi N., Summers C., Chilvers E.R. Advances in neutrophil biology: clinical implications. Chest 2008, 134:606-612.
17. Chang A.B., Redding G.J., Everard M.L. State of the Art - Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr Pulmonol 2008, 43:519-531.
18. Grimwood K. Airway microbiology and host defenses in paediatric non-CF bronchiectasis. Paediatr Respir Rev 2011, 12:111-118.
19. Redding G.J. Update on Treatment of Childhood Bronchiectasis unrelated to Cystic-Fibrosis. Paediatr Respir Rev 2011, 12:119-123.
20. Chang A.B., Grimwood K., Mulholland E.K., Torzillo P.J. Bronchiectasis in Indigenous children in remote Australian communities. A position statement. Med J Aust 2002, 177:200-204.
21. Pasteur M.C., Bilton D., Hill A.T. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010, 65:i1-i58.
22. Grol R., Dalhuijsen J., Thomas S., Veld C., Rutten G., Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998, 317:858-861.
23. Jones A.P., Wallis C.E., Kearney C.E. Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database of Systematic Reviews 2003, (Issue 3).
24. O'Donnell A.E., Barker A.F., Ilowite J.S., Fick R.B. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Gro up. Chest 1998, 113:1329-1334.
25. Desai M., Weller P.H., Spencer D.A. Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome. Pediatr Pulmonol 1995, 20:307-308.